The stock has experienced a significant downtrend over the provided 180-day period, falling from a high near $283 in early October 2025 to a current price of $215.88. The 6-month price change is -19.93%, substantially underperforming the S&P 500's -2.82% change over the same period. The stock has shown some recovery from its low point within the data, which was $180.38, but remains well below its 52-week high of $437.06. The current price is approximately 19.7% above its 52-week low but 50.6% below its 52-week high, indicating it is still trading in the lower portion of its annual range. Short-term performance shows a 1-month decline of -7.99%, which also underperformed the broader market's -5.25% drop, but a 3-month gain of 3.42% outperformed the S&P 500's -4.63% loss.

Revenue for Q4 2025 was $13.60 billion, showing a slight year-over-year decline of -2.33% from the prior year's Q4. Profitability metrics remain positive, with a net margin of 9.10% and an operating margin of 24.33% as per the valuation data. The company's financial health is characterized by a high debt-to-equity ratio of 6.05, indicating significant leverage. However, it generates substantial operating cash flow, with TTM free cash flow reported at $4.42 billion. Operational efficiency is reflected in a strong Return on Equity (ROE) of 31.06% and a Return on Assets (ROA) of 5.48%, suggesting effective use of shareholder capital and assets.